Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Saroja Pharma Industries IndiaNSE:SAROJA +3.15%15 Pretax Margin % is 2.70% as of Mar. 2025, which is 5% below its 10-year median of 2.84. GuruFocus rates NSE:SAROJA with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 958 Drug Manufacturers companies, Saroja Pharma Industries India ranks worse than 60.86% on this metric.
The historical rank and industry rank for Saroja Pharma Industries India's Pretax Margin % or its related term are showing as below:
NSE:SAROJA'
s Pretax Margin % Range Over the Past 10 Years
Min: 2.7 Med: 2.84 Max: 2.97
Current: 2.7
NSE:SAROJA's Pretax Margin % is ranked worse than 60.86% of 958
companies
in the Drug Manufacturers industry
Industry Median: 7.535
vs NSE:SAROJA: 2.70
Saroja Pharma Industries India (NSE:SAROJA) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Saroja Pharma Industries India Pretax Margin % Related Terms
Saroja Pharma Industries India Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saroja Pharma Industries India Pretax Margin % Chart
Saroja Pharma Industries India Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
Pretax Margin %
2.82
2.84
2.97
2.97
2.70
Saroja Pharma Industries India Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
Pretax Margin %
2.82
2.84
2.97
2.97
2.70
NSE:SAROJA vs ZTS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Saroja Pharma Industries India's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Saroja Pharma Industries India Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Saroja Pharma Industries India's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Saroja Pharma Industries India's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Saroja Pharma Industries India (NSE:SAROJA) has a Pretax Margin % of 2.70% as of Mar. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Saroja Pharma Industries India and its competitors. This is near median its historical median of 2.84. Over the past decade, Saroja Pharma Industries India's Pretax Margin % has ranged from 2.70 to 2.97. According to the industry distribution chart, Saroja Pharma Industries India ranks #583 out of 958 companies in the Drug Manufacturers industry, placing it in the top 60.9%.
Is Saroja Pharma Industries India's Pretax Margin % too high?
Saroja Pharma Industries India's current Pretax Margin % of 2.70% is near median its 10-year median of 2.84. Over the past 10 years, this metric has ranged from a low of 2.70 to a high of 2.97. The Drug Manufacturers industry median Pretax Margin % is 7.54. Saroja Pharma Industries India's value of 2.70% is 64.2% below this industry median. Based on the distribution chart, Saroja Pharma Industries India ranks #583 out of 958 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Saroja Pharma Industries India has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Saroja Pharma Industries India's Pretax Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Saroja Pharma Industries India ranks #583 out of 958 companies for Pretax Margin %. This places Saroja Pharma Industries India in the lower half of its industry. The industry median Pretax Margin % is 7.54. Saroja Pharma Industries India's value of 2.70% is 64.2% below this benchmark. Historically, Saroja Pharma Industries India's own Pretax Margin % has ranged from 2.70 to 2.97 over the past decade. While the company's 10-year median is 2.84 vs. the industry median of 7.54, Saroja Pharma Industries India has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.54, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saroja Pharma Industries India's current Pretax Margin % of 2.70% is 64.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Saroja Pharma Industries India and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saroja Pharma Industries India's current Pretax Margin % is 2.70%, which is near median its own 10-year median of 2.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saroja Pharma Industries India stock overvalued right now?
Saroja Pharma Industries India (NSE:SAROJA) has a current Pretax Margin % of 2.70%. The current Pretax Margin % is 2.70%, which is near median its 10-year median of 2.84 and 64.2% below the Drug Manufacturers industry median of 7.54. Saroja Pharma Industries India's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Saroja Pharma Industries India (NSE:SAROJA), the current Pretax Margin % is 2.70% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Saroja Pharma Industries India Ltd is a company engaged in the pharmaceutical and healthcare sector. The company trades in pharmaceutical active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents used for pharmaceutical products, including human and veterinary medicines. The company has only one reportable business segment, which is pharma chemicals, such as thionyl chloride and pharmaceutical intermediates. Geographically, it operates in India, Asia Pacific, Europe, and other regions, with the majority of its revenue generated from India.
15GF Score
Get the complete analysis for NSE:SAROJA
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:SAROJA has been successfully added to your 
